diabetic retinopathy
Google has unleashed a tidal wave of product and feature updates through the ongoing Google I/O developers’ conference, and it’s no surprise that the intersection of artificial intelligence and healthcare was a recurring spotlight among them.
The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR.
In new study published in Ophthalmology, Google AI researchers found that they could improve their AI disease detecting software by using a small subset of images adjudicated by ophthalmologists that specialize in retinal diseases.
Worldwide there are 422 million people living with diabetes, according to World Health Organization estimates.